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Total Synthesis of a Mycolic Acid from Mycobacterium tuberculosis
Nabil Tahiri, Peter Fodran, Dhineshkumar Jayaraman, Jeffrey Buter, Martin D. Witte,
Tonatiuh A. Ocampo, D. Branch Moody, Ildiko Van Rhijn und Adriaan J. Minnaard*
Abstract: In Mycobacterium tuberculosis, mycolic acids and
their glycerol, glucose, and trehalose esters („cord factor“)
form the main part of the mycomembrane. Despite their first
isolation almost a century ago, full stereochemical evaluation is
lacking, as is a scalable synthesis required for accurate
immunological, including vaccination, studies. Herein, we
report an efficient, convergent, gram-scale synthesis of four
stereo-isomers of a mycolic acid and its glucose ester. Binding
to the antigen presenting protein CD1b and T cell activation
studies are used to confirm the antigenicity of the synthetic
material. The absolute stereochemistry of the syn-methoxy
methyl moiety in natural material is evaluated by comparing its
optical rotation with that of synthetic material.
Introduction
Mycobacterium tuberculosis (Mtb), the causative agent of
tuberculosis, is by far the most lethal member of the family of
Mycobacteriaceae, causing around 10 million new infections
yearly.[1] The difficult diagnosis and treatment of tuberculosis
is reflected in high mortality rates (1.5 million in 2018), which
makes it the leading cause of death by a single infectious
agent worldwide.[1] This difficult treatment is in part caused by
the presence of the mycomembrane in the cell envelope of
Mtb, which consists largely of a-alkyl, b-hydroxy long-chain
(C70–C90) fatty acids, known as mycolic acids.[2,3] These
highly lipophilic fatty acids are categorized according to the
presence of unsaturations or cyclopropyl groups („a-mycolic
acid“), a methoxy, or a keto function in the main chain. As the
number of methylene units between these substituents is
variable, mycolic acids are found as an inseparable mixture of
homologues. Mycolic acids are found either as the free acids
or esterified to the arabinogalactan layer, trehalose, glucose
(glucose monomycolate; GMM) or glycerol.
The overall molecular structure of mycolic acids has been
elucidated in the late 1960s,[7–9] and several members have
been prepared by the group of Baird[10–13] including two
methoxy mycolic acid diastereomers (Figure 2, 1 c and 1 d).
The complete elucidation of their stereochemistry, however,
has so far not been achieved. Moody and co-workers
demonstrated that R,R stereochemistry of the a-alkyl, b-
hydroxy carboxylic acid is crucial for T cell recognition of
glucose monomycolate.[14] The stereochemistry of the a-
methyl methoxy moiety in methoxy mycolic acids was
inferred by Asselineau et al. to be S,S by comparison of
molar optical rotations of natural samples with those of
reference compounds.[7] For this, the authors applied the
principle of optical superposition, originally hypothesized by
Van’t Hoff.[15] This hypothesis states that stereocenters that
are remotely located do not influence each otherQs optical
rotation, which therefore can be added up to provide the
overall optical rotation. The analysis was supported by the
synthesis work of Baird et al., but it remained uncertain
whether this hypothesis was valid for mycolic acids as the
optical rotation of the cis-cyclopropyl ring in model systems
was immeasurably small, making the determination of its
absolute stereochemistry using this strategy impossible. Due
to the lack of other viable analytical techniques, the stereo-
chemistry of the cyclopropyl ring still remains to be deter-
mined.
Methoxy mycolic acids (Figure 1) appear, with some
exceptions, to be present only in pathogenic mycobacteria[3]
and are antigenic in serological assays[4] and T cell assays.[5,6]
Upon binding to the antigen-presenting protein CD1b,
mycolic acids and their glucose mycolates activate T cells.[16, 17]
For glucose monomycolates the type and length of the
mycolate does not influence the T cell stimulatory capacity.[17]
Crystallography of the trimolecular complex of CD1b,
glucose monomycolate and T cell receptor showed that the
glucose forms the T cell epitope on top of the CD1b protein
and stabilizes the complex.[18] No crystallographic data of
CD1b–mycolic acid are available, but it is known that the type
of functional groups in the chain and its length determine the
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level of T cell activation.[5, 6] We hypothesized that the
stereochemistry of the cyclopropyl and the a-methyl methoxy
moiety of mycolic acid might influence its capacity to bind
CD1b and activate T cells.
The development of mycolic acids and glucose monomy-
colates as potential antigens in vaccine development and
diagnostics requires synthetic material strictly free from
immunologically-active impurities. This was our incentive to
undertake the total synthesis of four stereoisomers of
methoxy mycolic acid (Scheme 1, so S,S and R,R-stereochem-
istry in the a-methyl methoxy moiety plus R,S and S,R-
stereochemistry in the cis-cyclopropyl moiety) and their
glucose esters. This endeavour required a drastic decrease in
the number of synthetic transformations compared to the
previous synthesis by Baird et al.[11] Therefore we opted for
incorporation of the Suzuki–Fu cross-coupling on several
places in the design. Although the Suzuki-Fu cross-cou-
pling[19] has hardly been applied in natural product synthesis,
we advocate the use of this Pd-catalysed sp3–sp3 cross-
coupling reaction as it avoids the various functional group
transformations and basic reaction conditions required for
Wittig-type and Julia-type reactions.
In order to gain access to the four diastereomers in
a convergent manner and on gram scale, we retrosynthetically
dissected the molecule in three fragments, each containing
a chiral segment (Scheme 1). Both enantiomers of fragments
B and C had to be prepared, and combined with the natural
enantiomer of fragment A. Whereas fragment B and C were
planned to be connected via a Suzuki–Fu cross-coupling
reaction, unification of C–B to A using this reaction could not
be achieved since, as model studies showed, with a cyclo-
propylmethyl bromide the reaction failed. A Julia–Kocienski
olefination was projected instead.
Results and Discussion
Synthesis of the Fragments
The a-branched b-hydroxy acid moiety in fragment A was
installed via an anti-selective Abiko–Masamune asymmetric
aldol reaction[20] between aldehyde 6 and chiral ester 9
(Scheme 2a). The synthesis of 6 started with a DIBAL
reduction of commercially available 2 to the corresponding
lactol 3, directly followed by a Wittig olefination with 4[21]
resulting in 5 in 70% yield over these two steps. The a,b-
unsaturated thioester 5 was then silylated, saturated, and
reduced to the aldehyde in a single step in 82% yield by
a Fukuyama reduction. Esterification of chiral auxiliary 8
with the acyl bromide of 7 gave 9 in nearly quantitative yield.
The subsequent Abiko–Masamune aldol reaction of 9 and 6
resulted in a rewarding dr of 9:1, and partial hydrolysis of the
TES ether. Therefore, the crude was treated with aqueous
HCl in THF and subsequently purified by column chroma-
tography to provide diol 10 in 55% yield and dr > 97:3. Bis-
TBS protection of 10, followed by a Suzuki-Fu coupling
reaction[19] with 1-hexadecene resulted in 11 in good yields,
and effectively installed the required a-chain. Selective
deprotection of the primary TBS ether with pyridine·HF,
followed by DMP oxidation of the primary alcohol to the
corresponding aldehyde resulted in fragment A.
The synthesis of fragment B started with the alkyne zipper
reaction[23] applied to commercial 12, followed by protection
of the alcohol to provide terminal alkyne 13 in 86% yield
(Scheme 2b). Deprotonation of 13 with n-BuLi at 0 8C
followed by addition to paraformaldehyde resulted in 14 in
70% yield. In our hands, Lindlar reduction of 14[24] to cis
allylic alcohol 15 resulted in a mixture with the trans isomer,
inseparable on silica and Ag-impregnated silica. Although
this problem was avoided by subjecting 14 to a P-2 nickel
reduction,[25] this time 1H-NMR indicated concomitant over-
reduction. Fortunately, separation of 15 from approximately
15% of the aliphatic alcohol succeeded with a single run on
a Ag-impregnated silica column in 73 % yield. Alkene 15 was
cyclopropanated with 95% ee (see SI), mediated by dioxa-
borolane 16 a or 16 b according to CharetteQs procedure
yielding the enantiomeric alcohols 17a and 17 b, respective-
ly.[26] The alcohols 17a and 17 b were subsequently converted
into their pivaloyl esters, and desilylated using TBAF to yield
both enantiomers of 18 in excellent yield over three steps,[22]
and bromination resulted in both enantiomers of fragment B.
Fragment B decomposed upon extended storage (longer than
one month) at 0 8C, and was therefore used within one week
after synthesis.
The synthesis of fragment C (Scheme 3 a) started with
a diastereoselective conjugate addition of MeLi to 19 a and its
enantiomer 19b.[11, 27] Then, LiAlH4 reduction followed by
bromination of 21 resulted in bromide 22 in good yields over
two steps. Chain extension was achieved by subjecting 22 to
a Suzuki-Fu cross-coupling[19] with 1-hexadecene. Acid hy-
drolysis of the acetal, followed by a one-pot tosylation of the
primary alcohol and intramolecular SN2 reaction went
smoothly, and yielded the corresponding epoxide 25 in
excellent yield over two steps. Epoxide opening with
Grignard reagent 26 using catalytic CuCl minimized the
formation of halohydrin by-products[28] and afforded the
secondary alcohol 27 in good yield. Finally, methylation of the
secondary hydroxyl using an excess of MeI and NaH resulted
in both enantiomers of fragment C in nearly quantitative
yields.
Scheme 1. Retrosynthetic analysis.
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Endgame of the Synthesis
With all three fragments in hand, we initiated the end-
game by yet another Suzuki-Fu cross-coupling to connect the
fragments B and C (Scheme 3b). Reductive removal of the
pivaloate, and a subsequent Mitsunobu reaction with 1-
phenyl-1H-tetrazole-5-thiol afforded the thio-ether in good
yields over three steps. Unfortunately, ammonium heptamo-
lybdate/H2O2 oxidation to sulfone 29 proved to be very
sluggish due to limited solubility of the starting material in
EtOH/THF, whereas oxidation with m-CPBA resulted in
a complex mixture of unidentifiable products. Although
oxidation with RuO4 was possible,
[29] concomitant oxidation
of the methoxy function to the ketone was hard to suppress.
Fortunately, acceptable rates in the ammonium heptamolyb-
date/H2O2 oxidation were achieved by addition of n-BuOH as
co-solvent, resulting in nearly quantitative yields of the
sulfone. Subsequently, we applied a Julia–Kocienski olefina-
tion for the final coupling of 29 with fragment A. Although
initially excellent yields (85–90 %) were achieved in this
reaction, at some point we suffered from irreproducible
yields, even when we applied starting materials that had
provided satisfactory yields earlier. We could circumvent this
problem by using an excess of lithiated 29, which was nearly
quantitatively recovered. With the complete backbone in
place, we subjected 30 to a diimide reduction[30] of the olefin,
followed by TBS deprotection with pyridine·HF in excellent
yield. The use of n-BuOH as cosolvent proved again to be
essential for acceptable conversion rates. As we were
reluctant to store large quantities of the mycolic acids because
of the potentially sensitive hydroxy acid moiety, the final step
was carried out portion-wise at sub-gram scale. Removal of
the chiral auxiliary with LiOH, LiOH/H2O2 or hydrogenolysis
were unsuccessful, but hydrolysis with 2 equiv of tetrabuty-
lammonium hydroxide (n-Bu4NOH) in THF at rt resulted in
complete and clean conversion, and yielded the desired
mycolic acids in sufficient purity and quantitative yields after
a straightforward pentane/acetonitrile extraction. Overall, the
Scheme 2. a. The synthesis of fragment A. a) DIBAL, CH2Cl2, @78 8C, 1 h; b) 4, THF/toluene (2:1), 75 8C, 16 h, (70% over two steps); c) Et3SiH,
Pd/C, acetone, 0 8C to rt, 6 h, (82%); d) (COBr)2, 8, pyridine, CH2Cl2, 0 8C to rt, 3 h (94%); e) Cy2BOTf, NEt3, THF, @78 8C, then 6, 16 h; f) 2m
HClaq, THF, rt, 2 h (55% over two steps, 67% yield brsm); g) TBSOTf, 2,6-lutidine, CH2Cl2, 0 8C to rt, 3 h (94%); h) 1-hexadecene, 9-BBN,
Pd(PCy3)2 (10 mol%), K3PO4·H2O, THF, rt, 16 h (87%); i) pyridine·HF, THF, 0 8C to rt, 4 h (95%); j) DMP, CH2Cl2, rt 1 h (96%). b. Synthesis of
fragment B. a) NaH, 1,3-diaminopropane, 70 8C, 1.5 h; b) TBDPSCl, CH2Cl2, 0 8C to rt, 16 h (86% over two steps); c) n-BuLi, paraformaldehyde,
THF, 0 8C to rt, 16 h (70%); d) NaBH4, Ni(OAc)2·4H2O, H2, ethylenediamine, EtOH, rt, 15 min (73%); e) 1,2-dimethoxyethane, diethylzinc,
diiodomethane, 16, CH2Cl2, @15 8C to rt, 16 h; f) PivCl, DMAP, pyridine, CH2Cl2, 0 8C to rt, 16 h; g) TBAF, THF, 0 8C to rt, 16 h ( 97% over three
steps); h) CBr4, PPh3, CH2Cl2, 0 8C to rt, 3 h (90%).
[22] DIBAL= diisobutylaluminium hydride, THF = tetrahydrofurane, TBSOTf = tert-Butyldimethyl-
silyltrifluoromethanesulfonate, 9-BBN= 9-borabicyclo(3.3.1)nonane, DMP =Dess–Martin periodinane, TBDPSCl = tert-Butyldiphenylsilyl chloride,
PivCl = pivaloyl chloride, TBAF = tetrabutylammonium fluoride.
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total synthesis of mycolic acid 1a was achieved in a longest
linear sequence of just 17 steps, in 15% yield. The corre-
sponding glucose esters (Figure 2, 32 a–d) were obtained in
two steps using a method developed by Prandi[31] (see SI for
experimental details and yields).
The Stereochemistry of Natural Methoxy Mycolic Acid
With all four diastereomers in hand, it was now possible to
prove or disprove the ascription of the absolute stereochem-
istry (S,S) of the syn-methoxy methyl moiety by Asselineau
et al.[7] An aliquot of the carboxylic acids was treated with
(trimethylsilyl)diazomethane in toluene/methanol to provide
the methyl esters (see SI). The [a]D of both methyl esters with
S,S configuration in the a-methyl methoxy segment (1a and
1d) was 08, which corresponds with the specific rotation of the
natural sample reported before.[7] Consequently, also the
specific molar rotations [F]D were 08. This supports the
previous assignment of the stereochemistry by Asselineau,
and Baird (for 1d). The [a]D for the diastereomers with R,R
configuration in the a-methyl methoxy segment was + 7.88
for 1b and + 7.98 for 1 c and similar to those reported by Baird
and co-workers for (synthetic) diastereomer 1c.[11] The [F]D
of 1b and 1c was + 998 and + 1008, respectively, and
comparable with the sum of the values of the [F]D of the a-
methyl methoxy and the b-hydroxy acid segments prepared
earlier by Asselineau (+ 908). Therefore, it is reasonable to
conclude that the remotely located stereocenters in methoxy
mycolic acid do not influence each otherQs optical rotation.
The principle of optical superposition is therefore applicable
here and the assignment of the absolute stereochemistry by
Asselineau is correct, although the stereochemistry in the
cyclopropyl ring remains to be determined (see below).
Next, we desired to determine whether our synthetic
methoxy mycolic acids are biologically active as antigens for
human T cells. In the presence of CD1b-expressing antigen-
presenting cells, all four synthetic stereoisomers of glucose
monomycolate activated the LDN5 T cell line in a dose-
dependent manner, as determined by release of the cytokine
Scheme 3. a) The synthesis of fragment C. a: MeLi·LiBr, Et2O, @78 8C, 4 h (92%); b: LiAlH4, THF, 0 8C, 1 h (quant.); c: CBr4, PPh3, CH2Cl2, 0 8C to
rt, 4 h (84%); d: 9-BBN, 1-hexadecene, K3PO4, cat. Pd(PCy3)2, THF, 16 h (84%); e: 2m HClaq, THF, 95 8C, 16 h; f : NaH, tosylimidazole, THF, rt,
16 h (90% over two steps); g: 26, CuCl (5 mol%), THF, @10 8C, 2 h (85%); h: MeI, NaH, THF, rt, 16 h (95%).[22] b) The endgame synthesis. a: 9-
BBN, 1-hexadecene, fragment B, K3PO4, Pd(PCy3)2 (7 mol%), THF, 16 h; b: LiAlH4, THF, 0 8C, 15 min (78% over two steps); c: phenyl-1H-
tetrazole-5-thiol, PPh3, DIAD, THF, 0 8C to rt, 1 h (96%); d: H2O2 (30%), (NH4)6Mo7O28·4 H2O, THF, EtOH, n-BuOH, rt, 5 d (99%); e: LiHMDS,
fragment A, @35 8C, 1 h (90%); f: flavine cat.,[30] hydrazine hydrate, THF, EtOH, n-BuOH, rt, 5–7 d (98%); g: HF·pyridine, CHCl3, 0 8C, 2 h (99%);
h: n-Bu4NOH, (1.5m in water), THF, rt, 16 h (95%).




7628 www.angewandte.de T 2020 Die Autoren. Verçffentlicht von Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Angew. Chem. 2020, 132, 7625 – 7630
Interleukine-2 (IL-2) (Figure 3a). The level of activation by
the four synthetic diastereomers, the natural long glucose
mycolate from Mycobacterium phlei, and the natural short
glucose monomycolate from Rodococcus equi, were compa-
rable. This was consistent with previous observations that
glucose monomycolate-specific T cells are insensitive to
variations in the distal parts of mycolic acid, but highly
sensitive to changes in or near the glucose.[17]
As for the T cell activation assays with free mycolic acid, it
is known from studies with natural mycolic acid isolates that
a T cell clone is typically more potently activated by a certain
type of mycolic acid (a-, keto-, or methoxy-) than by another.
The pattern of antigen potency is different for each T cell
clone. In the presence of CD1b-expressing antigen-presenting
cells, all four synthetic mycolic acids stimulated the T cell
clone 11 well at the highest concentration tested, 5 mg mL@1
(Figure 3b). The two synthetic mycolic acids with the S,S
configuration at the a-methyl methoxy segment, however,
were better agonists than those with R,R configuration, and
better than the natural mixture of Mtb-derived mycolic acids
when tested at the suboptimal concentration of 0.08 mgmL@1.
No significant difference was found for the stereochemistry at
the cyclopropyl group.
As an alternative bioassay, mycolic acid and glucose
monomycolate can be loaded into fluorescently labelled
CD1b tetramers in vitro. Tetramerized, fluorescently labelled
CD1b–lipid complexes („tetramers“) can be used to study
glucose mycolate[32] and mycolic acid[6] specific T cells at
single-cell level, in combination with fluorescently labelled
antibodies, in flow cytometry. The fluorescence level of the
cells is an indication of the strength of the interaction between
T cell receptor and antigenic target, CD1b–mycolate.
All synthetic glucose mycolates, when loaded into CD1b
tetramers, stained LDN5 well (Figure 3c). A minor but
noticeable difference in the mean fluorescence intensity
(MFI) is observed depending on the stereochemistry of the
a-methyl methoxy unit. The MFI with the GMMs with the S,S
configuration is twice as high as in those with the R,R
configuration. No noticeable difference is seen between the
tetramers loaded with the glucose mycolates that differ in the
stereochemistry of their cyclopropyl group.
For the mycolic acids, however, more distinct differences
are observed (Figure 3d). Tetramers loaded with mycolic
acids with the S,S-methoxy methyl unit give much higher
MFIs than their R,R counterparts.
In addition to the effects of the configuration of the
methoxy methyl group, mycolic acids with an R,S-cyclopropyl
unit have a moderately increased MFI compared to their S,R
counterparts (MFI compound 1d> 1a and compound 1c>
1b in Figure 3 d). If we assume that the naturally occurring
configuration of the cyclopropyl provides the best CD1b
loading or the highest affinity for the T cell receptor, this
observation suggests the R,S-stereochemistry of the cyclo-
propyl group in natural mycolic acids.
Conclusion
In conclusion, the synthetic route presented here provides
access to gram amounts of methoxy mycolic acid. The
successful repetitive application of the Suzuki–Fu cross-
Figure 2. Overview of the four diastereomeric mycolic acids (1a–d), glucose mycolates (32a–d), and methyl esters (33 a–d).
Figure 3. Biological validation of synthetic glucose methoxy mycolates
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coupling and the anti-selective Abiko–Masamune asymmetric
aldol reaction in this natural product synthesis are instru-
mental to this success. The availability of all four diastereo-
mers allowed to confirm the S,S stereochemistry of the
methoxy methyl function in natural methoxy mycolic acid, as
inferred by Asselineau and Baird. The T cell receptor is
sensitive to variations in the stereochemistry of the side chain
of free mycolic acid, and not in that of glucose monomycolate.
Although the absolute stereochemistry of the cis-cyclopropyl
function could not be established, the CD1b-free mycolic acid
tetramer staining experiments favour R,S stereochemistry.
The availability of large amounts of fully synthetic methoxy
mycolic acid and glucose mycolate (GMM) allows further
study into their application in vaccine development and
diagnostics.
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